SCHEMBL982286

SCHEMBL982286

FC(F)(F)c1cc(Cl)c(-n2cc(Br)c3ncccc32)c(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA2 P47869 9/20 0.39
GABRB2 P47870 9/20 0.39
KDM4E B2RXH2 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
GRIN2B Q13224 2/20 0.37
CBFB Q13951 1/20 0.37
PTPN6 P29350 1/20 0.36
PTPN11 Q06124 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
KMT2A Q03164 1/20 0.36
MKNK1 Q9BUB5 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35
GRM2 Q14416 1/20 0.35
GABRB3 P28472 3/20 0.35
GABRP O00591 2/20 0.35
GABRD O14764 2/20 0.35
GABRA1 P14867 2/20 0.35
GABRB1 P18505 2/20 0.35
GABRG2 P18507 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL980587 0.80 GABRA2 (0.40) GABRA2GABRB2KDM4EL3MBTL1GRIN2B
SCHEMBL2831553 0.79 MAPT (0.40) GABRA2GABRB2KDM4EMEN1ALDH1A1
SCHEMBL980293 0.74 RORC (0.37) GABRA2GABRB2KDM4EL3MBTL1GRIN2B
SCHEMBL6864489 0.71 GABRA2 (0.37) GABRA2GABRB2GABRB3GABRPGABRD
SCHEMBL15568529 0.68 RORC (0.59)
SCHEMBL10678734 0.67 GABRA2 (0.38) GABRA2GABRB2GABRB3GABRPGABRD
SCHEMBL2829188 0.67 MAPT (0.42) GABRA2GABRB2KDM4EMEN1ALDH1A1
SCHEMBL6867884 0.66 HPGD (0.36) GABRA2GABRB2KDM4EMEN1ALDH1A1
SCHEMBL3930034 0.65 PTPN6 (0.44) KDM4EL3MBTL1PTPN6PTPN11SMN1; SMN2
SCHEMBL2827266 0.65 BIRC5 (0.50) GABRA2GABRB2GABRB3GABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110021543-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS PESTICIDES NOVARTIS AG (CH) 2011-01-27 US disclosed
CN-101675056-A Heterocyclic compounds and their use as pesticides NOVARTIS AG 2010-03-17 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021543-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS PESTICIDES DDT, TYR, CAT GABRA2 1490/4885GABRB2 1376/4885KDM4E 883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.